These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 9951331)

  • 21. Relative efficacy of different immunization schedules for the prevention of serogroup C meningococcal disease: a model-based evaluation.
    De Wals P; Trottier P; Pépin J
    Vaccine; 2006 Apr; 24(17):3500-4. PubMed ID: 16517032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effectiveness and duration of the immunity of the vaccine against serogroup A+C meningococcus].
    García Comas L; Ramírez Fernández R; Castañeda López R; Sanz Moreno JC; Vázquez Moreno J; Lasheras Carbajo MD; Barranco Ordoñez D; Ruiz Contreras J; Jover Ibarra J
    Rev Esp Salud Publica; 2000; 74(4):425-31. PubMed ID: 11031853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Haemophilus influenzae type b invasive disease and meningococcal disease: incidence and characteristics in Barcelona, 1994-1995. Work Group IMS-IUSPC for Surveillance and Control of Meningitis].
    Beni C; Caylà JA; Jansà JM; Maldonado R; Pañella H; Rajmil L; Villalbí JR
    Med Clin (Barc); 1999 Jan; 112(1):1-4. PubMed ID: 10027177
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact and effectiveness of meningococcal C conjugate vaccine following its introduction in Spain.
    Larrauri A; Cano R; García M; Mateo Sd
    Vaccine; 2005 Jul; 23(32):4097-100. PubMed ID: 15908059
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Economic evaluation of meningococcal serogroup C conjugate vaccination programmes in The Netherlands and its impact on decision-making.
    Welte R; van den Dobbelsteen G; Bos JM; de Melker H; van Alphen L; Spanjaard L; Rümke HC; Postma MJ
    Vaccine; 2004 Dec; 23(4):470-9. PubMed ID: 15530695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Meningococcal disease in Spain, 1990-1997. Change in its epidemiological pattern].
    de Mateo Ontañón S
    Rev Esp Salud Publica; 2000; 74(4):387-96. PubMed ID: 11031848
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.
    Bettinger JA; Scheifele DW; Le Saux N; Halperin SA; Vaudry W; Tsang R;
    Pediatr Infect Dis J; 2009 Mar; 28(3):220-4. PubMed ID: 19209096
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of serogroup on the presentation, course, and outcome of invasive meningococcal disease in children in the Republic of Ireland, 1995-2000.
    Healy CM; Butler KM; Smith EO; Hensey OP; Bate T; Moloney AC; MacMahon P; Cosgrove J; Cafferkey MT
    Clin Infect Dis; 2002 May; 34(10):1323-30. PubMed ID: 11981727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China.
    Ni JD; Jin YH; Dai B; Wang XP; Liu DQ; Chen X; Zheng Y; Ye DQ
    Postgrad Med J; 2008 Feb; 84(988):87-92. PubMed ID: 18322129
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Norman epidemics: MenBvac vaccine].
    Floret D
    Arch Pediatr; 2007 Jun; 14(6):541-3. PubMed ID: 17446054
    [No Abstract]   [Full Text] [Related]  

  • 31. Serogroup C meningococcal conjugate vaccines: new preparations. Effective from age two months.
    Prescrire Int; 2003 Apr; 12(64):43-6. PubMed ID: 12675020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multicenter surveillance of invasive meningococcal infections in children.
    Kaplan SL; Schutze GE; Leake JA; Barson WJ; Halasa NB; Byington CL; Woods CR; Tan TQ; Hoffman JA; Wald ER; Edwards KM; Mason EO
    Pediatrics; 2006 Oct; 118(4):e979-84. PubMed ID: 17015517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A prospective study of the effectiveness of the New Zealand meningococcal B vaccine.
    Kelly C; Arnold R; Galloway Y; O'Hallahan J
    Am J Epidemiol; 2007 Oct; 166(7):817-23. PubMed ID: 17615088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
    Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statement on meningococcal vaccination for travellers. Committee to Advise on Tropical Medicine and Travel.
    CMAJ; 1995 Aug; 153(3):303-8. PubMed ID: 7614446
    [No Abstract]   [Full Text] [Related]  

  • 36. Effectiveness of serogroup C meningococcal polysaccharide vaccine: results from a case-control study in Quebec.
    De Wals P; Deceuninck G; De Serres G; Boivin JF; Duval B; Remis R; Massé R
    Clin Infect Dis; 2005 Apr; 40(8):1116-22. PubMed ID: 15791510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neisseria meningitidis carriage during an outbreak of serogroup C disease.
    Patrick DM; Champagne S; Goh SH; Arsenault G; Thomas E; Shaw C; Rahim T; Taha F; Bigham M; Dubenko V; Skowronski D; Brunham RC
    Clin Infect Dis; 2003 Nov; 37(9):1183-8. PubMed ID: 14557962
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serologic response to serogroup C meningococcal vaccine in Brazilian preschool children.
    Amato Neto V; Finger H; Gotschlich EC; Feldman RA; de Avila CA; Konichi SR; Laus WC
    Rev Inst Med Trop Sao Paulo; 1974; 16(3):149-53. PubMed ID: 4421873
    [No Abstract]   [Full Text] [Related]  

  • 39. The impact of meningococcal serogroup C conjugate vaccine in Scotland.
    Mooney JD; Christie P; Robertson C; Clarke SC
    Clin Infect Dis; 2004 Aug; 39(3):349-56. PubMed ID: 15307001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The 2001 serological survey in the Czech Republic--invasive meningococcal disease.
    Krízová P
    Cent Eur J Public Health; 2003 Dec; 11 Suppl():S62-7. PubMed ID: 15080262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.